Abstract
As the heterodimerization partner for a large number of nuclear receptors, the retinoid X receptor (RXR) is important for a large and diverse set of biochemical pathways. Activation and regulation of RXR heterodimers is achieved by complex allosteric mechanisms, which involve the binding of ligands, DNA, coactivators and corepressors, and entail large and subtle conformational motions. Complementing experiments, computer simulations have provided detailed insights into the origins of the allostery by investigating the changes in structure, motion, and interactions upon dimerization, ligand and cofactor binding. This review will summarize a number of simulation studies that have furthered the understanding of the conformational dynamics and the allosteric activation and control of RXR complexes. While the review focuses on the RXR and RXR heterodimers, relevant simulation studies of other nuclear receptors will be discussed as well.
Keywords: Retinoid X receptor, Nuclear receptor, Simulation, Molecular dynamics, Allostery, Conformational dynamics.
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:Computer Simulations of the Retinoid X Receptor: Conformational Dynamics and Allosteric Networks
Volume: 17 Issue: 6
Author(s): Arjan van der Vaart, Alexander Lorkowski, Ning Ma and Geoffrey M. Gray
Affiliation:
Keywords: Retinoid X receptor, Nuclear receptor, Simulation, Molecular dynamics, Allostery, Conformational dynamics.
Abstract: As the heterodimerization partner for a large number of nuclear receptors, the retinoid X receptor (RXR) is important for a large and diverse set of biochemical pathways. Activation and regulation of RXR heterodimers is achieved by complex allosteric mechanisms, which involve the binding of ligands, DNA, coactivators and corepressors, and entail large and subtle conformational motions. Complementing experiments, computer simulations have provided detailed insights into the origins of the allostery by investigating the changes in structure, motion, and interactions upon dimerization, ligand and cofactor binding. This review will summarize a number of simulation studies that have furthered the understanding of the conformational dynamics and the allosteric activation and control of RXR complexes. While the review focuses on the RXR and RXR heterodimers, relevant simulation studies of other nuclear receptors will be discussed as well.
Export Options
About this article
Cite this article as:
Vaart van der Arjan, Lorkowski Alexander, Ma Ning and Gray M. Geoffrey, Computer Simulations of the Retinoid X Receptor: Conformational Dynamics and Allosteric Networks, Current Topics in Medicinal Chemistry 2017; 17 (6) . https://dx.doi.org/10.2174/1568026616666160617084745
DOI https://dx.doi.org/10.2174/1568026616666160617084745 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Identification of a RhoA- and SRF-Dependent Mechanism of Androgen Action that is Associated with Prostate Cancer Progression
Current Drug Targets Adenoviral Vectors for Cancer Gene Therapy
Current Genomics MicroRNAs: Potential Diagnostic and Therapeutic Targets for Breast Cancer
Epigenetic Diagnosis & Therapy (Discontinued) Treatment of Psoriasis: A Comprehensive Review of Entire Therapies
Current Drug Safety Kinase Inhibitor Conjugates
Current Pharmaceutical Design Cell Responses to Oxidative Stressors
Current Pharmaceutical Design Subject Index To Volume 7
Current Drug Targets Pentoxifylline Use in Dermatology
Inflammation & Allergy - Drug Targets (Discontinued) Notch Signaling Proteins: Legitimate Targets for Cancer Therapy
Current Protein & Peptide Science Angiogenesis Markers in Gynecological Tumors and Patents for Anti- Angiogenic Approach: Review
Recent Patents on Anti-Cancer Drug Discovery Patents on Enhancing the Potency and Longevity of Highly Valuable Protein Hormones
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Hepatocyte Growth Factor Receptor: Structure, Function and Pharmacological Targeting in Cancer
Current Signal Transduction Therapy Potential MicroRNA Targets for Cancer Chemotherapy
Current Medicinal Chemistry Targeting of Nuclear Factor-κB and Proteasome by Dithiocarbamate Complexes with Metals
Current Pharmaceutical Design Angiogenesis Inhibition: State of the Art, Forgotten Strategies and New Perspectives in Cancer Therapy
Current Cancer Therapy Reviews Radiation and Gene Therapy: Rays of Hope for the New Millennium?
Current Gene Therapy Molecular Dynamics and Structural Studies of the Ets Domain-DNA Complexes
Current Bioinformatics CEBP Epigenetic Dysregulation as a Drug Target for the Treatment of Hematologic and Gynecologic Malignancies
Current Drug Targets The Potential of 11C-acetate PET for Monitoring the Fatty Acid Synthesis Pathway in Tumors
Current Pharmaceutical Biotechnology Current Status and Future Prospects for Research on Tyrosine Sulfation
Current Pharmaceutical Biotechnology